scispace - formally typeset
S

Sten-Magnus Aquilonius

Researcher at Uppsala University

Publications -  123
Citations -  6164

Sten-Magnus Aquilonius is an academic researcher from Uppsala University. The author has contributed to research in topics: Levodopa & Spinal cord. The author has an hindex of 45, co-authored 123 publications receiving 5901 citations. Previous affiliations of Sten-Magnus Aquilonius include Uppsala University Hospital.

Papers
More filters
Journal ArticleDOI

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

TL;DR: Continuous intraduodenal infusion of the levodopa/carbidopa enteral gel as monotherapy is safe and clinically superior to a number of individually optimized combinations of conventional oral and subcutaneous medications in patients with motor fluctuations.
Journal ArticleDOI

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

TL;DR: Suicide enzyme inactivators labeled with positron emitters can be used to quantitate the distribution and kinetic characteristics of MAO in human brain structures and show rapid clearance of the inactive enantiomer and retention of the active enantiomers within MAO B-rich brain structures.
Journal ArticleDOI

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

TL;DR: In postmortem investigations of patients with dementia of Alzheimer type (AD/SDAT) the brain weight was significantly reduced when compared to controls and the activity of monoamine oxidase B was increased suggesting a proliferation of extra neuronal tissue in the AD/ SDAT-brains.
Journal ArticleDOI

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets.

TL;DR: Continuous intraduodenal delivery of a new carbidopa/levodopa formulation offers a means for markedly improved control of motor fluctuations in late stages of PD.
Journal Article

Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.

TL;DR: Postmortem examination of various brain regions of cases without known brain pathology showed an age-related decrease in the levels of dopamine in the nigrostriatal system, of norepinephrine in the hippocampus, and of 5-HT in the gyrus cinguli but an increase in the medulla oblongata and of MAO B in several brain regions.